Table 3.
Recovery Efficiency Compared with Manual and Between EZ1 Viral Kits
| Serial dilutions | |||
|---|---|---|---|
| A. Compared to Manual | |||
| BP-BAL | |||
| Sample | 10−1 | 10−2 | 10−3* |
| Manual | 100 | 100 | 100 |
| EZ1 | 102 | 99 | 102 |
| easyMag | 103 | 100 | 100 |
| Mpn-ETT | |||
| Sample | 10−1 | 10−2 | 10−3* |
| Manual | 100 | 100 | 100 |
| EZ1 | 95 | 94 | 95 |
| easyMag | 92 | 86 | n/a† |
| BK-Plasma | |||
| Sample | 10−1 | 10−2 | 10−3* |
| Manual | 100 | 100 | 100 |
| EZ1 | 103 | 108 | 105 |
| easyMag | 103 | 108 | 102 |
| HSVII-CSF EZ1 viral kit version 1.0 | |||
| Sample | 10−1 | 10−2 | 10−3* |
| Manual | 100 | 100 | 100 |
| EZ1 | 103 | 95 | 96 |
| easyMAG | 103 | 104 | 100 |
| B. EZ1 viral kit version 1.0 versus 2.0 | |||
| EV-CSF EZ1 viral kit version 1.0 | |||
| Sample | 10−1 | 10−2 | 10−3* |
| Manual | 100 | 100 | 100 |
| EZ1 | 83 | 85 | 87 |
| easyMAG | 97 | 97 | 96 |
| EV-CSF EZ1 viral kit version 2.0 | |||
| Sample | 10−1 | 10−2 | 10−3* |
| Manual | 100 | 100 | 100 |
| EZ1 | 97 | 98 | 101 |
| easyMAG | 94 | 95 | 97 |
HSVII-CSF, herpes simplex virus II-cerebrospinal fluid; EV, Enterovirus coxsackie A9.
10−3 dilution represents a Ct of approximately 35.
n/a indicates that no samples were positive at that dilution, so recovery efficiency could not be calculated.